Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 192

1.

Hepatoid adenocarcinoma in Barrett's esophagus associated with achalasia: first case report.

Tanigawa H, Kida Y, Kuwao S, Uesugi H, Ojima T, Kobayashi N, Saigenji K, Okayasu I.

Pathol Int. 2002 Feb;52(2):141-6. Review.

PMID:
11940219
2.

Origin of adenocarcinoma in Barrett's esophagus: p53 and Ki67 expression and histopathologic background.

Szachnowicz S, Cecconello I, Iriya K, Marson AG, Takeda FR, Gama-Rodrigues JJ.

Clinics (Sao Paulo). 2005 Apr;60(2):103-12.

3.

Histopathologic evaluation of an animal model for Barrett's esophagus and adenocarcinoma of the distal esophagus.

Buskens CJ, Hulscher JB, van Gulik TM, Ten Kate FJ, van Lanschot JJ.

J Surg Res. 2006 Oct;135(2):337-44.

PMID:
16926029
4.

Mucin expression and proliferating cell index of esophageal Barrett's adenocarcinoma.

Yamamoto S, Kijima H, Hara T, Chino O, Shimada H, Tanaka M, Inokuchi S, Makuuchi H.

Int J Mol Med. 2005 Sep;16(3):375-80.

PMID:
16077942
5.

Coexistent multiple adenocarcinomas arising in Barrett's esophagus 23 years after total gastrectomy and esophageal small cell carcinoma.

Noguchi T, Takeno S, Sato T, Uchida Y, Daa T, Yokoyama S.

Jpn J Thorac Cardiovasc Surg. 2003 Jun;51(6):259-62.

PMID:
12831243
6.

Prevalence of Barrett's esophagus and expression of mucin antigens detected by a panel of monoclonal antibodies in Barrett's esophagus and esophageal adenocarcinoma in Japan.

Azuma N, Endo T, Arimura Y, Motoya S, Itoh F, Hinoda Y, Irimura T, Hosokawa M, Imai K.

J Gastroenterol. 2000;35(8):583-92.

PMID:
10955596
7.

Adenocarcinoma of the upper esophagus arising in heterotopic gastric mucosa: common pathogenesis with Barrett's adenocarcinoma?

Chatelain D, de Lajarte-Thirouard AS, Tiret E, Flejou JF.

Virchows Arch. 2002 Oct;441(4):406-11. Review.

PMID:
12516606
8.

"Barrett's esophagus" adenocarcinoma: a case report.

Nakamura T, Tohyama H, Nagamachi Y.

Jpn J Surg. 1980 Jun;10(2):137-41.

PMID:
7431687
9.

Barrett's esophagus and achalasia.

Guo JP, Gilman PB, Thomas RM, Fisher RS, Parkman HP.

J Clin Gastroenterol. 2002 Apr;34(4):439-43. Review.

PMID:
11907357
10.

Frequent methylation of eyes absent 4 gene in Barrett's esophagus and esophageal adenocarcinoma.

Zou H, Osborn NK, Harrington JJ, Klatt KK, Molina JR, Burgart LJ, Ahlquist DA.

Cancer Epidemiol Biomarkers Prev. 2005 Apr;14(4):830-4.

11.

AFP-producing hepatoid adenocarcinoma in association with Barrett's esophagus with multiple liver metastasis responding to paclitaxel/CDDP: a case report.

Chiba N, Yoshioka T, Sakayori M, Mikami Y, Miyazaki S, Akiyama S, Otsuka K, Yamaura G, Shibata H, Kato S, Kato S, Ishioka C.

Anticancer Res. 2005 Jul-Aug;25(4):2965-8. Erratum in: Anticancer Res. 2006 Jul-Aug;26(4b):3203. Yoshiki, Mikami [corrected to Mikami, Yoshiki].

12.

Barrett's esophagus (BE) and carcinoma in the esophageal stump (ES) after esophagectomy with gastric pull-up in achalasia patients: a study based on 10 years follow-up.

da Rocha JR, Ribeiro U Jr, Sallum RA, Szachnowicz S, Cecconello I.

Ann Surg Oncol. 2008 Oct;15(10):2903-9. doi: 10.1245/s10434-008-0057-1.

PMID:
18618179
13.

Proinflammatory cytokine and nuclear factor kappa-B expression along the inflammation-metaplasia-dysplasia-adenocarcinoma sequence in the esophagus.

O'Riordan JM, Abdel-latif MM, Ravi N, McNamara D, Byrne PJ, McDonald GS, Keeling PW, Kelleher D, Reynolds JV.

Am J Gastroenterol. 2005 Jun;100(6):1257-64.

PMID:
15929754
14.

Adenocarcinoma complicating Barrett's esophagus: an analysis of cell proliferation.

Matsumoto Y, Arai N, Mieno H, Murakami K, Ishii K, Mitomi H.

J Gastroenterol. 2001 Jun;36(6):410-4.

PMID:
11428588
15.

Collision carcinoma of the residual cervical esophagus 27 years after esophageal cancer surgery.

Naritaka Y, Ogawa K, Shimakawa T, Wagatsuma Y, Isohata N, Asaka S, Miyaki A, Shiozawa S, Katsube T, Yoshimatsu K, Aiba M, Ide H.

Anticancer Res. 2007 Jan-Feb;27(1B):505-11.

16.

The sequential model of Barrett's esophagus and adenocarcinoma induced by duodeno-esophageal reflux without exogenous carcinogens.

Sato T, Miwa K, Sahara H, Segawa M, Hattori T.

Anticancer Res. 2002 Jan-Feb;22(1A):39-44.

PMID:
12017320
17.

Esophageal polypoid dysplasia of gastric foveolar phenotype with focal intramucosal carcinoma associated with Barrett's esophagus.

Asthana N, Mandich D, Ligato S.

Am J Surg Pathol. 2008 Oct;32(10):1581-5. doi: 10.1097/PAS.0b013e3181753aa6.

PMID:
18724240
18.

Risk factors, DNA damage, and disease progression in Barrett's esophagus.

Olliver JR, Hardie LJ, Gong Y, Dexter S, Chalmers D, Harris KM, Wild CP.

Cancer Epidemiol Biomarkers Prev. 2005 Mar;14(3):620-5.

19.

Cell kinetic study on histogenesis of Barrett's esophagus using rat reflux model.

Kumagai H, Mukaisho K, Sugihara H, Bamba M, Miyashita T, Miwa K, Hattori T.

Scand J Gastroenterol. 2003 Jul;38(7):687-92.

PMID:
12889552
20.

Adenocarcinoma arising in Barrett's esophagus after total gastrectomy.

Tada T, Suzuki T, Iwafuchi M, Watanabe H, Katayanagi N, Aizawa K, Nishimaki T, Tanaka O, Muto T.

Am J Gastroenterol. 1990 Nov;85(11):1503-6.

PMID:
2239878
Items per page

Supplemental Content

Support Center